Health-care giant Johnson & Johnson (JNJ) is shutting a biotechnology research facility outside Sydney as part of a cost-cutting effort spurred on by challenging conditions in pharmaceutical markets.
Health-care giant Johnson & Johnson (JNJ) is shutting a biotechnology research facility outside Sydney as part of a cost-cutting effort spurred on by challenging conditions in pharmaceutical markets.
